Existing backer Legend Capital contributed to an eight-figure dollar round for the chemistry services provider having initially invested in 2017.

China-based chemistry services provider Bellen has received tens of millions of dollars in a series D round featuring Legend Capital, the venture capital firm spun off by conglomerate Legend Holdings, DealStreetAsia reported yesterday.

Huagai Capital and Eastern Bell Capital co-led the round while CICC Capital’s CICC Qichen fund, Apricot Capital and Insight Capital also invested, according to a WeChat post cited by DealStreetAsia.

Bellen provides chemistry services for pharmaceutical developers, assisting with chemical synthesis and the development of research and…

Robert Lavine

Robert Lavine is special features editor for Global Venturing.